Analyst Ratings For ANCHIANO THERAP/S ADR (NASDAQ:ANCN)

Today, LADENBURG THALM/SH SH initiated coverage on ANCHIANO THERAP/S ADR (NASDAQ:ANCN) with a Buy.

There are 2 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.

The current consensus rating on ANCHIANO THERAP/S ADR (NASDAQ:ANCN) is Buy with a consensus target price of $16.00 per share, a potential 107.79% upside.

Some recent analyst ratings include

• 3/11/2019-ANCHIANO THERAP/S ADR (NASDAQ:ANCN) has coverage initiated with a Buy rating
• 3/11/2019-ANCHIANO THERAP/S ADR (NASDAQ:ANCN) has coverage initiated with a Outperform rating and $16.00 price target

Recent Trading Activity for ANCHIANO THERAP/S ADR (NASDAQ:ANCN)
Shares of ANCHIANO THERAP/S ADR closed the previous trading session at 7,70 −0,015 0,19 % with 7.7 shares trading hands.